Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 29.3996
- Book/Share 6.5677
- PB 3.7547
- Debt/Equity 2.8949
- CurrentRatio 2.9121
- ROIC 0.0522
- MktCap 999558749.0
- FreeCF/Share 1.2113
- PFCF 20.375
- PE 31.4145
- Debt/Assets 0.5846
- DivYield 0.0243
- ROE 0.1237
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
4 Stocks Trading Near 52-Week High With Room to Rise Further
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors target stocks that have been on a bullish run lately. Stocks like DB, HRTG, PAHC and TGI are seeing price strength and the momentum is likely to continue.
Read More
Best Growth Stocks to Buy for May 23rd
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, GLDD and UIS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 23, 2025.
Read More
Best Value Stocks to Buy for May 23rd
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 23, 2025.
Read More
Best Income Stocks to Buy for May 23rd
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
FLNG, MDLZ and PAHC made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 23, 2025.
Read More
What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
3 Reasons Growth Investors Will Love Phibro (PAHC)
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC's third-quarter fiscal 2025 results reflect the strength of the Animal Health segment.
Read More
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.31 per share a year ago.
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: April 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
The heavy selling pressure might have exhausted for Phibro (PAHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Here is Why Growth Investors Should Buy Phibro (PAHC) Now
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
Read More
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Negative
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Read More
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Published: April 08, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.
Read More
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?
Published: March 10, 2025 by: Zacks Investment Research
Sentiment: Neutral
PAHC stays on investors' radar due to its Animal Health business and potential in emerging markets.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Jack Clifford Bendheim
- Employees 1940